AstraZeneca Pharma India is undertaking a recall of sterile products manufactured at its facility in Bangalore, following an internal audit conducted by the company. This recall is a purely voluntary action on the part of the company taken as a measure of extra and abundant caution although there is no patient safety issue reported relating to sterility.
The company firmly believes that the health and safety of the end users of these products is of paramount and overriding importance. With this the company is ensuring that international quality standards are maintained globally on a consistent basis.
Further, a temporary interruption of supplies of affected products is expected. The company is also exploring all options to resume quality supplies of its sterile products at the earliest opportunity.
AstraZeneca Pharma India is engaged in the business of manufacturing and marketing pharmaceutical products in healthcare segments namely gastrointestinal, cardiovascular, cancer, respiratory, neurosciences and infection.
